Shared neoantigens for cancer immunotherapy
Exploration of neoantigens holds the potential to be productive in immuno-oncotherapy. Among tumor-specific antigens, neoantigens result from genetic instability that gives rise to non-synonymous somatic mutations, highly specific to tumor cells. In addition to point mutations, gene rearrangements,...
Saved in:
| Main Authors: | Anastasia Goloudina, Fabien Le Chevalier, Pierre Authié, Pierre Charneau, Laleh Majlessi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Molecular Therapy: Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2950329925000475 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer
by: Joanna Fréderique de Graaf, et al.
Published: (2024-09-01) -
Neoantigens: new hope for cancer therapy
by: Yitong Hu, et al.
Published: (2025-03-01) -
Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy
by: Shinji Morisaki, et al.
Published: (2025-05-01) -
Identification of shared neoantigens derived from frameshift mutations in the APC gene
by: Peng Zhao, et al.
Published: (2025-05-01) -
Shared neoantigens’ atlas for off-the-shelf cancer vaccine development
by: Angela Mauriello, et al.
Published: (2025-05-01)